F · Healthcare
Drug Manufacturers - Specialty & Generic
Hisamitsu Pharmaceutical Co. Inc (HPX) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $2.30B, P/E ratio is 21.78, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Hisamitsu Pharmaceutical Co. Inc (HPX) has a reported market cap of $2.30B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for Hisamitsu Pharmaceutical Co. Inc (HPX) is 21.78 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for Hisamitsu Pharmaceutical Co. Inc (HPX). Check the MyAverix Finance app for the latest dividend data.
Hisamitsu Pharmaceutical Co. Inc (HPX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
HPX is listed on F.
Hisamitsu Pharmaceutical Co. Inc (HPX) reports a net margin of 0.0% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.